Chronic Cerebrospinal Venous Insufficiency has generated interest in the media and MS patient and scientific communities recently, but a new paper challenges the role of CCSVI in multiple sclerosis.
Impaired drainage from the brain and spinal cord, CCSVI, has been suggested to be a phenomenon seen exclusively in MS. Its proposed treatment using balloon angioplasty or stents has also been undertaken in small studies.
However a new paper published in the Annals of Neurology examines the recent investigations that led to the groundswell.
Based on this evaluation of the science of CCSVI, Multiple Sclerosis Research Australia discourages patients with MS from any invasive procedures until there is more conclusive evidence to justify their benefit for treating MS.
Eleven world experts in MS, radiology and medicine have now reviewed what is currently known about CCSVI, the validity of the experiments undertaken to link CCSVI and the development of MS and the steps required to prove CCSVI and its treatment can benefit People with MS.
To read the full report and details of the investigative study, click here.
